Drug-labels.com

Bacitracin USP: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Current status: Cancelled Post Market
Strength:
50000 UNIT
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Bacitracin USP

ABOUT THIS MEDICATION

What the medication is used for:

BACITRACIN USP can be used by a healthcare professional in the treatment of infants with pneumonia and empyema (accumulation of pus in the chest) caused by staphylococci (bacteria) and administered by injection in the muscle. BACITRACIN can also be used as a topically applied solution to treat infected wounds, ulcers, pyodermas and other superficial skin and eye infections under the supervision of a healthcare professional.

Antibacterial drugs like Bacitracin USP treat only bacterial infections. They do not treat viral infections such as the common cold. Although you may feel better early in treatment, Bacitracin USP should be used exactly as directed. Misuse or overuse of Bacitracin USP could lead to the growth of bacteria that will not be killed by Bacitracin USP (resistance). This means that Bacitracin USP may not work for you in the future. Do not share your medicine.

What it does:

BACITRACIN USP is an antibiotic that treats against a variety of organisms.

When it should not be used:

Do not take BACITRACIN USP if you:

  • are allergic to BACITRACIN
  • are allergic to any of the other ingredients in BACITRACIN or to a component of the container.

What the medicinal ingredient is:

The active ingredient is bacitracin.

What the important nonmedicinal ingredients are:

There are no nonmedicinal ingredients.

What dosage forms it comes in:

BACITRACIN USP is available in a vial containing 50,000 units, packaged in cartons of 5’s.

WARNINGS AND PRECAUTIONS

Serious Warnings and Precautions

BACITRACIN can cause serious side effects which include:

  • Damage to the kidneys including kidney failure. Kidney failure is a condition where your kidneys stop working.
  • Serious allergic reactions

BEFORE Bacitracin is administered to you or you use Bacitracin topically, talk to your doctor or pharmacist if:

You have or have had kidney problems

Any allergies to this drug

Intramuscular bacitracin can cause kidney failure. Kidney function will be carefully determined by the doctor before and daily during your therapy. Contact your doctor immediately and stop taking Bacitracin if the signs of kidney problems occur, with symptoms such as urinating less than usual or not at all, blood in the urine, lower back pain, or painful urination.

As with other antibiotics, this drug may cause an overgrowth of non-susceptible organisms, including fungi. If a superinfection occurs, talk to your doctor to start appropriate treatment.

INTERACTIONS WITH THIS MEDICATION

Do not use BACITRACIN USP at the same time as other nephrotoxic drugs, especially streptomycin kanamycin, polymyxin B, polymyxin E (colistin), neomycin, and viomycin.

PROPER USE OF THIS MEDICATION

Usual dose:

Infant dose:

As determined by the doctor: For infants under 2500 grams – 900 units/kg/24 hours in 2 or 3 divided doses. For infants over 2500 grams – 1000 units/kg/24 hours in 2 or 3 divided doses, by intramuscular injection.

Preparation of Solutions for Intramuscular Use or Topical Use:

Overdose:

If you think you, or a person you are caring for, have taken too much Bacitracin, contact a healthcare professional, hospital emergency department, or regional poison control center immediately, even if there are no symptoms.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Other reactions include nausea and vomiting, pain at injection site, and skin rashes.

BACITRACIN may cause abnormal blood test results. Your healthcare professional will decide when to perform blood tests and will interpret the results. They will check your kidney function before you receive BACITRACIN and while you are receiving it.

SERIOUS SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Symptom / effectTalk with your doctor or pharmacistStop taking drug and get immediate medical help
Only if severeIn all cases
Uncommo nDamage to the kidneys including kidney failure: (back and abdominal pain, change in the colour of urine (pale or dark), decrease in amount of urine produced, nausea, pain or discomfort when urinating, swelling of the legs and ankles, tiredness, weight gain.)√√
Allergic reactions: difficulty breathing or swallowing, feeling sick to your stomach or vomiting, hives, itchy skin, rash, skin blisters, swelling of your tongue or throat√√

This is not a complete list of side effects. For any unexpected effects while taking BACITRACIN, contact your doctor or pharmacist.

HOW TO STORE IT

Store unreconstituted BACITRACIN in a refrigerator 2-8°C. Solutions are rapidly inactivated at room temperature but are stable for one week when stored in a refrigerator 2-8°C.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

If you want more information about BACITRACIN:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (https://health-products.canada.ca/dpd-bdpp/index-eng.jsp); the manufacturer’s website (www.pfizer.ca), or by calling 1-800-463-6001.

Last Revised: September 15, 2021

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 00030708

Revision date stated in the text: September 15, 2021

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Bacitracin USP

DIN 00030708
Schedule(s) ETHICAL
Active ingredient(s) Bacitracin 50000 UNIT
Dosage form(s) Powder For Solution
Route(s) of administration Intramuscular, Topical
Drug class (WHO ATC)
  1. J Antiinfectives for systemic use
    1. J01 Antibacterials for systemic use
      1. J01X Other antibacterials
        1. J01XX Other antibacterials
          1. J01XX10 Bacitracin
Company PFIZER CANADA ULC
Current status Cancelled Post Market
Current status date March 31, 2021

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.